We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
-3.97%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$484B
AUM Growth
-$4.92B
Cap. Flow
+$23.6B
Cap. Flow %
4.87%
Top 10 Hldgs %
31.76%
Holding
15,382
New
1,669
Increased
5,510
Reduced
5,992
Closed
1,922

Sector Composition

Rank Sector Weight
1 Technology 2.74%
2 Healthcare 2.42%
3 Financials 2.31%
4 Consumer Discretionary 1.76%
5 Industrials 1.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FWONA icon
10501
CALL
Liberty Media Series A
FWONA
$24.2B
$297K ﹤0.01%
+4,909
New +$266K
GLP icon
10502
PUT
Global Partners
GLP
$1.7B
$297K ﹤0.01%
10,900
-8,600
-44% -$226K
INDI icon
10503
PUT
indie Semiconductor
INDI
$864M
$297K ﹤0.01%
38,000
-83,500
-69% -$685K
TFFP
10504
PUT
DELISTED
TFF Pharmaceuticals, Inc. Common Stock
TFFP
$297K ﹤0.01%
1,880
-2,048
-52% -$331K
APTV.PRA
10505
DELISTED
Aptiv PLC 5.50% Series A Mandatory Convertible Preferred Shares
APTV.PRA
$297K ﹤0.01%
2,171
-9,130
-81% -$1.38M
CLPR
10506
PUT
Clipper Realty
CLPR
$53M
$296K ﹤0.01%
32,600
-29,100
-47% -$272K
FOLD
10507
PUT
DELISTED
Amicus Therapeutics
FOLD
$296K ﹤0.01%
31,300
-13,700
-30% -$128K
PGX icon
10508
Invesco Preferred ETF
PGX
$3.77B
$296K ﹤0.01%
21,845
-17,930
-45% -$250K
USRT icon
10509
iShares Core US REIT ETF
USRT
$4.65B
$296K ﹤0.01%
+4,582
New +$288K
CLVR
10510
PUT
DELISTED
Clever Leaves Holdings Inc. Common Shares
CLVR
$296K ﹤0.01%
3,960
+2,377
+150% +$129K
AMRX icon
10511
PUT
Amneal Pharmaceuticals
AMRX
$6.15B
$295K ﹤0.01%
70,800
-14,000
-17% -$62K
CCSI icon
10512
PUT
Consensus Cloud Solutions
CCSI
$713M
$295K ﹤0.01%
4,900
+545
+13% +$31.5K
GRTX
10513
CALL
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
$295K ﹤0.01%
123,800
-36,000
-23% -$93.8K
CAPR icon
10514
PUT
Capricor Therapeutics
CAPR
$383M
$294K ﹤0.01%
85,700
-15,900
-16% -$62.7K
DLHC icon
10515
PUT
DLH Holdings
DLHC
$67.7M
$294K ﹤0.01%
+15,500
New +$274K
NINE
10516
CALL
DELISTED
Nine Energy Service
NINE
$294K ﹤0.01%
78,500
+32,800
+72% +$61.7K
SON icon
10517
PUT
Sonoco
SON
$5.74B
$294K ﹤0.01%
+4,700
New +$272K
VRN
10518
CALL
DELISTED
Veren
VRN
$294K ﹤0.01%
40,500
+13,500
+50% +$91.1K
APGB.WS
10519
DELISTED
Apollo Strategic Growth Capital II Warrants, each exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share
APGB.WS
$294K ﹤0.01%
506,499
+108,983
+27% +$75.4K
BTG icon
10520
CALL
B2Gold
BTG
$6.82B
$293K ﹤0.01%
63,800
+44,300
+227% +$178K
CWEB icon
10521
CALL
Direxion Daily CSI China Internet Index Bull 2X ETF
CWEB
$227M
$293K ﹤0.01%
4,740
-1,150
-20% -$117K
IDT icon
10522
PUT
IDT Corp
IDT
$1.66B
$293K ﹤0.01%
8,600
-3,600
-30% -$134K
MRTN icon
10523
Marten Transport
MRTN
$1.25B
$293K ﹤0.01%
16,470
-36,544
-69% -$640K
OSUR icon
10524
CALL
OraSure Technologies
OSUR
$268M
$293K ﹤0.01%
43,200
-41,600
-49% -$332K
PJUN icon
10525
Innovator US Equity Power Buffer ETF June
PJUN
$978M
$293K ﹤0.01%
+9,101
New +$289K

Similar funds

Citadel Advisors's Q1 2022 Portfolio in Review

As of Q1 2022, Citadel Advisors held 15,382 positions worth $484B, down 1% from $489B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Citadel Advisors deployed $23.6B of net new capital in Q1 2022, opening 1,669 new positions and adding to 5,510 existing holdings. Its largest new stake was iShares 20+ Year Treasury Bond ETF: 3,151,731 shares worth $416M.

By sector, the portfolio is most concentrated in Technology at 2.7% of assets, down from 3.1% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was NVIDIA, an estimated $518M trimmed.

  • Citadel Advisors's largest Q1 2022 buy was iShares 20+ Year Treasury Bond ETF: 3,151,731 shares worth $416M.
  • Citadel Advisors added most to State Street SPDR S&P 500 ETF Trust in Q1 2022, an estimated $555M increase.
  • Citadel Advisors's biggest Q1 2022 reduction was NVIDIA, cutting an estimated $518M.
  • Citadel Advisors fully exited IHS Markit Ltd. Common Shares in Q1 2022, selling an estimated $535M.
  • Citadel Advisors's ten largest holdings make up 32% of its $484B portfolio in Q1 2022.
  • Citadel Advisors opened 1,669 new positions and closed 1,922 in Q1 2022.
  • Citadel Advisors's portfolio value fell 1% quarter-over-quarter to $484B.

Based on Citadel Advisors's 13F filing for Q1 2022, filed 16 May 2022.